Edition:
United Kingdom

Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

85.31USD
25 Apr 2019
Change (% chg)

-- (--)
Prev Close
$85.31
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
380,347
52-wk High
$106.69
52-wk Low
$79.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 353.21 -0.021
Sep '18 391.71 -0.071
Jun '18 372.85 -0.095
Mar '18 373.45 -0.277
FY 2017 Dec '17 358.30 -0.052
Sep '17 334.15 -0.072
Jun '17 317.45 -0.211
Mar '17 303.74 -0.094
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 20 414.47 433.60 392.56 429.67
Quarter Ending Sep-19 20 437.62 455.60 427.00 449.75
Year Ending Dec-19 26 1,694.14 1,737.00 1,661.30 1,735.60
Year Ending Dec-20 26 1,946.94 2,114.00 1,779.90 2,032.09
Earnings (per share)
Quarter Ending Jun-19 20 -0.14 -0.02 -0.28 0.07
Quarter Ending Sep-19 20 -0.03 0.16 -0.12 0.13
Year Ending Dec-19 23 -0.41 -0.15 -0.61 0.22
Year Ending Dec-20 23 0.28 1.31 -0.69 1.25
LT Growth Rate (%) 1 47.20 47.20 47.20 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 62.05 62.41
P/E High - Last 5 Yrs. -- 49.11 56.04
P/E Low - Last 5 Yrs. -- 27.56 28.58
Beta 1.48 0.93 0.93
Price to Sales (TTM) 10.24 7.45 9.51
Price to Book (MRQ) 5.12 4.00 4.57
Price to Tangible Book (MRQ) 6.70 7.28 7.95
Price to Cash Flow (TTM) 1,100.27 43.63 43.28
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.68 1.53
Dividend Yield - 5 Year Avg -- 0.71 0.70
Dividend 5 Year Growth Rate -- 2.09 2.99
Payout Ratio(TTM) -- 21.52 21.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -1.42 7.46 8.96
Sales (TTM) vs TTM 1 Yr. Ago 13.52 4.46 7.86
Sales - 5 Yr. Growth Rate 22.14 9.66 10.98
EPS (MRQ) vs Qtr. 1 Yr. Ago 60.41 132.88 106.33
EPS (TTM) vs TTM 1 Yr. Ago -8.10 -- --
EPS - 5 Yr. Growth Rate -- 5.16 6.92
Capital Spending - 5 Yr. Growth Rate 17.28 6.54 7.57

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.92 2.67 2.66
Current Ratio (MRQ) 3.93 3.69 3.64
LT Debt to Equity (MRQ) 27.98 12.60 13.39
Total Debt to Equity (MRQ) 27.98 15.27 17.10
Interest Coverage (TTM) -7.41 13.66 12.94

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 78.86 51.75 50.47
Gross Margin - 5 Yr. Avg. 81.28 49.92 50.84
EBITD Margin (TTM) -6.17 -- --
EBITD - 5 Yr. Avg -10.83 17.21 15.86
Operating Margin (TTM) -8.28 3.81 -1.64
Operating Margin - 5 Yr. Avg. -20.61 13.51 11.17
Pre-Tax Margin (TTM) -9.57 2.96 -2.45
Pre-Tax Margin - 5 Yr. Avg. -23.18 20.10 16.64
Net Profit Margin (TTM) -5.49 -0.80 -6.36
Net Profit Margin - 5 Yr. Avg. -19.56 15.01 11.65
Effective Tax Rate (TTM) -- 22.70 22.81
Effective Tax Rate - 5 Yr. Avg. -- 23.64 23.87

Efficiency

  Company industry sector
Revenue/Employee (TTM) 523,416 905,491,548 772,647,503
Net Income/Employee (TTM) -28,716 104,303,081 88,992,312
Receivable Turnover (TTM) 4.94 5.43 5.23
Inventory Turnover (TTM) 0.63 2.62 3.64
Asset Turnover (TTM) 0.33 0.84 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -1.81 9.97 9.56
Return on Assets - 5 Yr. Avg. -5.98 11.03 10.48
Return on Investment (TTM) -2.12 12.20 11.81
Return on Investment - 5 Yr. Avg. -6.84 14.06 13.37
Return on Equity (TTM) -2.83 13.14 12.64
Return on Equity - 5 Yr. Avg. -9.33 15.29 14.84
  1 Year 3 Year 5 Year
Sales % 13.52 18.78 22.14
EPS (TTM) % -1.77 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Biomarin Pharmaceutical Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.79 -6.83 99 28
13 Week -8.65 -17.65 94 15
26 Week -7.96 -16.48 99 59
52 Week 5.37 -5.16 99 56
YTD 0.40 -14.02 99 21
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 681
Total Shares Held: 183,408,601
3 Mo. Net Change: 220,609
# New Positions: 14
# Closed Positions: 6
# Increased Positions: 61
# Reduced Positions: 34
# Net Buyers: 27
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.